# Pfizer Inc. (PFE) — Q4-2021 Earnings Results

**Report date:** 2022-02-08 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q4-2021

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 2.84%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.08 | N/A | +27.06% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their pipeline and future prospects. However, they acknowledged external challenges that could impact growth.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing challenges in supply chain but remain focused on innovation.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report showed a strong EPS beat, which indicates better-than-expected profitability. However, the stock fell by 2.84%, likely due to the absence of revenue figures and guidance, leaving investors uncertain about future performance. The cautious tone from management regarding external challenges may have also contributed to the stock's decline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q4-2021_